A study has identified a new mechanism for how a gene mutation leads to the death of neurons in amyotrophic lateral sclerosis and a related form of dementia.
Xinkun Wang, PhD, director of the NUSeq Core Facility, supports the research of scientists throughout the medical school with the latest genomic technologies, including next-generation sequencing.
A study published in Neuron suggests the brain’s own compensatory mechanisms contribute to the debilitating motor symptoms of Parkinson’s disease.
A comprehensive genomic analysis of the most common kidney cancer in children – found genetic mutations involving two distinct processes, potentially providing new opportunities for future treatments.
The major features of Parkinson’s disease have been linked to a toxic cascade beginning with oxidized dopamine, providing a possible therapeutic pathway.
Northwestern Medicine research has explained the mechanism behind ‘pauses’ in transcription, which has implications for future cancer therapies.
Hossein Ardehali, MD, PhD, has been named the new director of Feinberg’s Medical Scientist Training Program; Melissa Brown, PhD, has been named associate director of advising and Xunrong Luo, MD, PhD, the associate director of admissions for the program.
Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
The drug idarucizumab rapidly reversed the anticoagulant effects of the blood-thinner dabigatran in emergency situations, according to a recent phase III clinical trial.
Graduate students and postdoctoral fellows in the biomedical field gathered for an all-day symposium dedicated to showcasing research and exploring career options.